Who owns BRAINSTORM CELL THERAPEUTICS?
- Ticker: BCLI
- CUSIP Number: 10501e300
Tip: Access positions for across all investors
Analyze quarterly positions in Brainstorm Cell Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Brainstorm Cell Therapeutics stock
Who bought or sold BRAINSTORM CELL THERAPEUTICS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| VSM Wealth Advisory | 120.00 | $84.996000 | 0% | Sep 2025 |
|
Who sold out of Brainstorm Cell Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| BlackRock | Jun 2025 | 25k | $28k |
| Raymond James Financial | Jun 2025 | 5.2k | $5.8k |
| Advisor Group Holdings | Sep 2025 | 1.8k | $1.4k |
| Bangor Savings Bank | Sep 2025 | 266.00 | $188.008800 |
| SBI Securities | Jun 2025 | 218.00 | $244.007400 |
| Jones Financial Companies, L.L | Jun 2025 | 216.00 | $229.003200 |